Cite
HARVARD Citation
Lu, Y. et al. (n.d.). 35TiPRibociclib plus goserelin with hormonal therapy versus physician choice chemotherapy in pre-/perimenopausal patients with HR+, HER2– inoperable locally advanced breast cancer (ABC): RIGHT choice study. Annals of oncology. p. . [Online].